Sad but expected. Also not described here are the brain drain into PE and VC to fund a slew of AI startups that will likely go nowhere for their new chatbot or drug designer agent.
Sad but expected. Also not described here are the brain drain into PE and VC to fund a slew of AI startups that will likely go nowhere for their new chatbot or drug designer agent.